Fig 1: Comparison of MDSCs, MDSC subsets, and MDSC effectors between the pneumonia group and the stable group. (A) The percentages of MDSCs, CD11b+CD14−CD15+ LDG G-MDSCs and CD11b+CD14+HLA-DRlow/−CD15− M-MDSCs in peripheral blood mononuclear cells (PBMCs) in the pneumonia group (n = 58) and the stable group (n = 29). Tested by the Mann–Whitney U test. (B) MDSC effectors, such as Arg-1, S100A8/A9 and S100A12, in the pneumonia group (n = 58) and the stable group (n = 14). Tested by the Mann–Whitney U test. For S100A12, the left Y axis represents the pneumonia group and the right Y axis represents the stable group. MDSC, myeloid-derived suppressor cell; LDG, low-density granulocyte; G-MDSC, granulocytic-MDSC; M-MDSC, monocytic-MDSC; PBMCs, peripheral blood mononuclear cells; Arg-1, arginase-1.
Fig 2: Comparison of MDSCs, MDSC subsets, and MDSC effectors between the severe pneumonia subgroup and the non-severe pneumonia subgroup. (A) The percentages of MDSCs, CD11b+CD14-CD15+ LDG G-MDSCs and CD11b+CD14+HLA-DRlow/-CD15- M-MDSCs in PBMCs in the severe pneumonia subgroup (n = 18) and the non-severe pneumonia subgroup (n = 40). Tested by the Mann–Whitney U test. (B) MDSC effectors, such as Arg-1, S100A8/A9, and S100A12, in the severe pneumonia subgroup (n = 18) and the non-severe pneumonia subgroup (n = 40). Tested by the Mann–Whitney U test. MDSC, myeloid-derived suppressor cell; LDG, low-density granulocyte; G-MDSC, granulocytic-MDSC; M-MDSC, monocytic-MDSC; PBMCs, peripheral blood mononuclear cells; Arg-1, arginase-1.
Supplier Page from Abcam for Human S100A12 ELISA Kit